In its Q1 fiscal 2026 financials, BD trimmed its EPS outlook by more than $2 at the high end due to the spin-off of its ...

Becton, Dickinson and Company BDX, popularly known as BD, recently announced that it has completed the previously disclosed ...

After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest its diagnostic and biosciences businesses as the company nears the finish ...

BD (NYSE: BDX) shares dipped before hours today despite first-quarter results that came in ahead of the consensus Wall Street ...

BD is recognized as one of the leading medical technology companies worldwide, with a substantial market capitalization of $59.35 billion and annual revenue exceeding $20.6 billion. The company is ...

Medical tech company BD (Becton, Dickinson and Co.) acquired MedKeeper, a provider of cloud-based pharmacy management applications, the Franklin Lakes firm announced July 28. The deal – terms of which ...

Analysts have also predicted that the company will be profitable this year, a positive sign that may reassure investors looking for stable earnings amidst the acquisition. Despite the challenges of ...

Company’s latest solutions are designed to empower healthcare providers across the Middle East region, strengthen patient ...

After nearly a century spent building out its portfolio of insulin pens and syringes, BD is finally ready to let its diabetes care business leave the nest. While reporting financial results for the ...

Medical technology company Becton, Dickinson and Company (NYSE:BDX) will be reporting results this Monday before the bell. Here’s what to expect.